Switch theme
Sign up to access all valuation multiples
CLIO Cosmetics Co Ltd is engaged in the manufacturing and distribution of cosmetic products. The company offers a wide range of cosmetic, makeup and skincare products. Its brand portfolio comprises clio, peripera, goodal, healing bird and dermatory.
1997
n/a
LTM Revenue $245M
LTM EBITDA $20.6M
$141M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CLIO Cosmetics has a last 12-month revenue of $245M and a last 12-month EBITDA of $20.6M.
In the most recent fiscal year, CLIO Cosmetics achieved revenue of $239M and an EBITDA of $23.9M.
CLIO Cosmetics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CLIO Cosmetics valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $225M | $239M | XXX | XXX | XXX |
| Gross Profit | $91.9M | $113M | XXX | XXX | XXX |
| Gross Margin | 41% | 47% | XXX | XXX | XXX |
| EBITDA | $26.4M | $23.9M | XXX | XXX | XXX |
| EBITDA Margin | 12% | 10% | XXX | XXX | XXX |
| Net Profit | $6.9M | $18.9M | XXX | XXX | XXX |
| Net Margin | 3% | 8% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, CLIO Cosmetics's stock price is KRW 19190 (or $13).
CLIO Cosmetics has current market cap of KRW 336B (or $229M), and EV of KRW 207B (or $141M).
See CLIO Cosmetics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $141M | $229M | XXX | XXX | XXX | XXX | $1.09 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, CLIO Cosmetics has market cap of $229M and EV of $141M.
CLIO Cosmetics's trades at 0.6x LTM EV/Revenue multiple, and 6.8x LTM EBITDA.
Analysts estimate CLIO Cosmetics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for CLIO Cosmetics and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $141M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 5.9x | XXX | XXX | XXX |
| P/E | 12.1x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 12.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCLIO Cosmetics's NTM/LTM revenue growth is 9%
CLIO Cosmetics's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, CLIO Cosmetics's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate CLIO Cosmetics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for CLIO Cosmetics and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -10% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 19% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 28% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 42% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CLIO Cosmetics acquired XXX companies to date.
Last acquisition by CLIO Cosmetics was XXXXXXXX, XXXXX XXXXX XXXXXX . CLIO Cosmetics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was CLIO Cosmetics founded? | CLIO Cosmetics was founded in 1997. |
| Where is CLIO Cosmetics headquartered? | CLIO Cosmetics is headquartered in South Korea. |
| Who is the CEO of CLIO Cosmetics? | CLIO Cosmetics's CEO is Ms. Hyeon-Ok Han. |
| Is CLIO Cosmetics publicy listed? | Yes, CLIO Cosmetics is a public company listed on KRX. |
| What is the stock symbol of CLIO Cosmetics? | CLIO Cosmetics trades under 237880 ticker. |
| When did CLIO Cosmetics go public? | CLIO Cosmetics went public in 2016. |
| Who are competitors of CLIO Cosmetics? | Similar companies to CLIO Cosmetics include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of CLIO Cosmetics? | CLIO Cosmetics's current market cap is $229M |
| What is the current revenue of CLIO Cosmetics? | CLIO Cosmetics's last 12-month revenue is $245M. |
| What is the current EBITDA of CLIO Cosmetics? | CLIO Cosmetics's last 12-month EBITDA is $20.6M. |
| What is the current EV/Revenue multiple of CLIO Cosmetics? | Current revenue multiple of CLIO Cosmetics is 0.6x. |
| What is the current EV/EBITDA multiple of CLIO Cosmetics? | Current EBITDA multiple of CLIO Cosmetics is 6.8x. |
| What is the current revenue growth of CLIO Cosmetics? | CLIO Cosmetics revenue growth between 2023 and 2024 was 6%. |
| Is CLIO Cosmetics profitable? | Yes, CLIO Cosmetics is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
